UBS analyst John Hodulik lowered the firm’s price target on Charter (CHTR) to $355 from $425 and keeps a Neutral rating on the shares. Competition persists and there will be tougher comps ahead, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CHTR: